Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study
Open Access
- 26 July 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 720716
- https://doi.org/10.3389/fimmu.2021.720716
Abstract
Objetive: To address the prevalence of SARS-CoV-2 and the evolutionary profile of immune compounds in breastmilk of positive mothers according to time and disease state. Methods: Forty-five women with term pregnancies with confirmed non-severe SARS-CoV-2 infection (case group), and 96 SARS-CoV-2 negative women in identical conditions (control group) were approached, using consecutive sample. Weekly (1st to 5th week postpartum) reverse transcription polymerase chain reaction (RT-PCR) in nasopharyngeal swabs (cases) and breastmilk (cases and controls) were obtained. Concentration of cytokines, chemokines, and growth factors in breastmilk (cases and controls) were determined at 1st and 5th week post-partum. Results: Thirty-seven (study group) and 45 (control group) women were enrolled. Symptomatic infection occurred in 56.8% of women in the study group (48% fever, 48% anosmia, 43% cough). SARS-CoV-2 RNA was not found in breastmilk samples. Concentrations of cytokines (IFN-γ, IL-1ra, IL-4, IL-6, IL-9, IL-13, and TNF-α) chemokines (eotaxin, IP-10, MIP-1α, and RANTES) and growth factors (FGF, GM-CSF, IL7, and PDGF-BB) were higher in breastmilk of the study compared with the control group at 1st week postpartum. Immune compounds concentrations decreased on time, particularly in the control group milk samples. Time of nasopharyngeal swab to become negative influenced the immune compound concentration pattern. Severity of disease (symptomatic or asymptomatic infection) did not affect the immunological profile in breast milk. Conclusions: This study confirms no viral RNA and a distinct immunological profile in breastmilk according to mother’s SARS-CoV-2 status. Additional studies should address whether these findings indicate efficient reaction against SARS-CoV-2 infection, which might be suitable to protect the recipient child.Funding Information
- Instituto de Salud Carlos III (COV20/01046)
- Ministerio de Ciencia, Innovación y Universidades (BES-2017-080713)
This publication has 48 references indexed in Scilit:
- Bacteriological, Biochemical, and Immunological Properties of Colostrum and Mature Milk From Mothers of Extremely Preterm InfantsJournal of Pediatric Gastroenterology and Nutrition, 2015
- Changes in immunomodulatory constituents of human milk in response to active infection in the nursing infantPediatric Research, 2011
- Milk Epidermal Growth Factor and Gut ProtectionThe Journal of Pediatrics, 2010
- Cytokines in Human MilkThe Journal of Pediatrics, 2010
- Milk-Derived Transforming Growth Factor-β and the Infant Immune ResponseThe Journal of Pediatrics, 2010
- Neonatal Tolerance under Breastfeeding Influence: The Presence of Allergen and Transforming Growth Factor-β in Breast Milk Protects the Progeny from Allergic AsthmaThe Journal of Pediatrics, 2010
- High Concentrations of Interleukin 15 in Breast Milk Are Associated with Protection against Postnatal HIV TransmissionThe Journal of Infectious Diseases, 2009
- Longitudinal Comparison of Chemokines in Breastmilk Early Postpartum Among HIV-1-Infected and Uninfected Kenyan WomenBreastfeeding Medicine, 2007
- Immunomodulatory constituents of human milk change in response to infant bronchiolitisPediatric Allergy and Immunology, 2007
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006